- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
bioMérieux Corporate Website | Pioneering diagnostics
13 November, 2018 bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with...
09 November, 2018 bioMérieux acquires a majority stake in Hybiome and strengthens i...
18 October, 2018 Business review for the nine months ended September 30, 2018
05 September, 2018 First-Half 2018 Results
Specialized in automated immunoassay tests, Hybiome develops, manufactures and markets a complete range of diagnostic solutions cleared by the China Food and Drug Administration. Thanks to this acquisition, we strengthen our presence both in China and in the immunoassay market.
Our test for the detection of endotoxins in pharmaceutical microbiology control, ENDOZYME® II GO, has been shortlisted as one of the winners in the Medicine Maker Innovation Awards 2018. These awards recognize innovative technologies launched in 2018 to support pharma development and manufacturing.